Breaking News Instant updates and real-time market news.

JAZZ

Jazz Pharmaceuticals

$136.54

-0.84 (-0.61%)

16:02
08/12/19
08/12
16:02
08/12/19
16:02

Jazz Pharmaceuticals announces acquisition of Cavion

Jazz Pharmaceuticals announced the acquisition of Cavion through a merger with a Jazz subsidiary. Under the terms of the agreement, the former Cavion shareholders receive an upfront payment of $52.5M and have the potential to receive additional payments of up to $260M upon the achievement of certain clinical, regulatory and commercial milestones, for a total potential consideration of $312.5M.

  • 20

    Aug

  • 04

    Sep

  • 09

    Sep

JAZZ Jazz Pharmaceuticals
$136.54

-0.84 (-0.61%)

07/03/19
MZHO
07/03/19
NO CHANGE
Target $148
MZHO
Neutral
Mizuho more cautious on Jazz's Sunosi after last night's update
Mizuho analyst Irina Koffler says Jazz Pharmaceuticals last night provided a commercial update on Sunosi ahead of its July 8 launch with lower pricing and higher discounting than she previously modeled. The company views its market opportunity as consisting of 165,000 patients in narcolepsy, and another 12M patients with sleep apnea, Koffler tells investors in a research note. Wholesale acquisition cost pricing has been set at $660 per month, below the analyst's $900 per month estimate. Koffler is now more conservative on Sunosi following last night's update and she reiterates a Neutral rating on Jazz shares with a $148 price target.
07/03/19
LEHM
07/03/19
NO CHANGE
Target $164
LEHM
Overweight
Jazz launch update suggests upside to estimates, says Barclays
Barclays analyst Balaji Prasad says last night's Sunosi launch update from Jazz Pharmaceuticals suggests upside to his estimates. Management guided to $500M in U.S. sales by 2025, suggesting potential upside to the analyst's $300M 2025 U.S. estimate. Prasad adds that while the stock has increased ~20% in the last month, he remains confident in the opportunity and further ~15% upside implied in his price target of $164. The analyst keeps an Overweight rating on Jazz Pharmaceuticals.
07/03/19
RBCM
07/03/19
NO CHANGE
Target $184
RBCM
Outperform
RBC Capital raises peak potential on Jazz Pharmaceuticals' Sunosi after update
RBC Capital analyst Randall Stanicky kept his Outperform rating and $184 price target on Jazz Pharmaceuticals after his discussions with the company detailing its launch plans and commercial landscape for Sunosi which received a Schedule IV designation last month. The analyst notes that while only a limited contribution is expected from the program this year, the company forecast a "more bullish peak outlook than expected" at over $500M in the US.
08/07/19
LEHM
08/07/19
NO CHANGE
Target $180
LEHM
Overweight
Jazz Pharmaceuticals price target raised to $180 from $164 at Barclays
Barclays analyst Balaji Prasad raised his price target for Jazz Pharmaceuticals to $180 from $164 saying Xyrem outperformed Q2 while Sunosi "looks promising" and the pipeline expands. The analyst has a "strong" outlook for Jazz's sleep franchise and keeps an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

ALSN

Allison Transmission

$43.06

-0.96 (-2.18%)

15:30
08/23/19
08/23
15:30
08/23/19
15:30
Conference/Events
Allison Transmission management to meet with RBC Capital »

Meeting to be held In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

15:30
08/23/19
08/23
15:30
08/23/19
15:30
General news
Treasury Action: bond yields have inched up from intraday lows »

Treasury Action: bond…

IWM

iShares Trust Russell 2000 Index Fund

$146.13

-3.92 (-2.61%)

, RUT

Russell 2000 Index

$0.00

(0.00%)

15:22
08/23/19
08/23
15:22
08/23/19
15:22
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

The Russell 2000 (RUT) at…

IWM

iShares Trust Russell 2000 Index Fund

$146.13

-3.92 (-2.61%)

RUT

Russell 2000 Index

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
08/23/19
08/23
15:17
08/23/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
08/23/19
08/23
15:16
08/23/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$12.53

-0.24 (-1.88%)

15:15
08/23/19
08/23
15:15
08/23/19
15:15
Options
Fiat Chrysler put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$285.78

-6.58 (-2.25%)

15:12
08/23/19
08/23
15:12
08/23/19
15:12
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

At time of writing the…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$285.78

-6.58 (-2.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDOG

Datadog

$0.00

(0.00%)

15:11
08/23/19
08/23
15:11
08/23/19
15:11
Syndicate
Datadog files S-1 for IPO, seeks to list on Nasdaq with symbol 'DDOG' »

Datadog filed an S-1 with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIIQ

Health Insurance Innovations

$18.17

-0.87 (-4.57%)

15:05
08/23/19
08/23
15:05
08/23/19
15:05
Options
Health Insurance Innovations call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 20

    Sep

INCY

Incyte

$82.37

-3.2 (-3.74%)

, LLY

Eli Lilly

$110.50

-1.13 (-1.01%)

14:58
08/23/19
08/23
14:58
08/23/19
14:58
Hot Stocks
Eli Lilly, Incyte announce baricitinib meets primary endpoint in Phase 3 trial »

Eli Lilly (LLY) and…

INCY

Incyte

$82.37

-3.2 (-3.74%)

LLY

Eli Lilly

$110.50

-1.13 (-1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Sep

  • 09

    Sep

  • 16

    Sep

  • 02

    Oct

  • 23

    Oct

EPD

Enterprise Products

$28.35

-0.605 (-2.09%)

14:55
08/23/19
08/23
14:55
08/23/19
14:55
Options
Enterprise Products put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

LGF.A

Lionsgate

$10.52

-0.28 (-2.59%)

, LGF.B

Lionsgate

$10.01

-0.205 (-2.01%)

14:54
08/23/19
08/23
14:54
08/23/19
14:54
On The Fly
Box Office Battle: 'Angel has Fallen' looking to swoop into top spot »

Welcome to "Box Office…

LGF.A

Lionsgate

$10.52

-0.28 (-2.59%)

LGF.B

Lionsgate

$10.01

-0.205 (-2.01%)

SNE

Sony

$53.87

-0.91 (-1.66%)

CMCSA

Comcast

$42.75

-1.01 (-2.31%)

CMCSK

Comcast

$0.00

(0.00%)

T

AT&T

$34.95

-0.44 (-1.24%)

CBS

CBS

$42.02

-1.43 (-3.29%)

DIS

Disney

$133.09

-2.98 (-2.19%)

VIA

Viacom

$27.31

-0.28 (-1.01%)

VIAB

Viacom

$25.01

-0.85 (-3.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 05

    Sep

  • 05

    Sep

  • 10

    Sep

  • 11

    Sep

  • 23

    Oct

  • 27

    Oct

QSR

Restaurant Brands

$76.37

0.94 (1.25%)

14:45
08/23/19
08/23
14:45
08/23/19
14:45
Options
Restaurant Brands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:45
08/23/19
08/23
14:45
08/23/19
14:45
General news
Fed funds futures surge on the downdraft in stocks »

Fed funds futures surge…

OSW

OneSpaWorld

$15.84

-0.22 (-1.37%)

14:41
08/23/19
08/23
14:41
08/23/19
14:41
Conference/Events
OneSpaWorld management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 28

    Aug

OPRX

OptimizeRx

$15.16

-0.39 (-2.51%)

14:38
08/23/19
08/23
14:38
08/23/19
14:38
Conference/Events
OptimizeRx management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 12

    Sep

APPN

Appian

$60.63

0.29 (0.48%)

14:37
08/23/19
08/23
14:37
08/23/19
14:37
Conference/Events
Appian management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 27

    Aug

ET

Energy Transfer LP

$13.35

-0.31 (-2.27%)

14:35
08/23/19
08/23
14:35
08/23/19
14:35
Options
Energy Transfer put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKTR

Nektar

$17.04

0.05 (0.29%)

14:25
08/23/19
08/23
14:25
08/23/19
14:25
Options
Nektar call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

14:20
08/23/19
08/23
14:20
08/23/19
14:20
General news
Treasury Action: yields remain sharply lower on a flight to safety »

Treasury Action: yields…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
08/23/19
08/23
14:17
08/23/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBGI

Sinclair Broadcast

$43.19

-1.24 (-2.79%)

, DIS

Disney

$133.27

-2.8 (-2.06%)

14:16
08/23/19
08/23
14:16
08/23/19
14:16
Periodicals
Sinclair CEO eyes more regional sports network acquisitions, WSJ reports »

Sinclair Broadcast (SBGI)…

SBGI

Sinclair Broadcast

$43.19

-1.24 (-2.79%)

DIS

Disney

$133.27

-2.8 (-2.06%)

T

AT&T

$34.97

-0.425 (-1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 10

    Sep

  • 11

    Sep

  • 23

    Sep

  • 23

    Oct

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
08/23/19
08/23
14:16
08/23/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANG

Diamondback Energy

$95.83

-3.315 (-3.34%)

14:15
08/23/19
08/23
14:15
08/23/19
14:15
Options
Diamondback Energy put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 11

    Sep

14:10
08/23/19
08/23
14:10
08/23/19
14:10
General news
Action Economics Survey results: »

Action Economics Survey…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.